Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-18

Clinical Trial Update: Drotaverine to Shorten the Length of Labor [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating drotaverine for shortening the length of labor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drotaverine (drotaverine)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Prolonged First Stage of Labor, Failure of Cervical Dilation as Antepartum Condition | Phase 2, Phase 3 | Status: COMPLETED